BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 10382630)

  • 1. Natural history of chronic hepatitis B and C.
    Imperial JC
    J Gastroenterol Hepatol; 1999 May; 14 Suppl():S1-5. PubMed ID: 10382630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural history of chronic hepatitis B virus infection in adults with emphasis on the occurrence of cirrhosis and hepatocellular carcinoma.
    Chu CM
    J Gastroenterol Hepatol; 2000 May; 15 Suppl():E25-30. PubMed ID: 10921378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural history of hepatitis C virus infection: from chronic hepatitis to cirrhosis, to hepatocellular carcinoma.
    Leone N; Rizzetto M
    Minerva Gastroenterol Dietol; 2005 Mar; 51(1):31-46. PubMed ID: 15756144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does antiviral therapy for hepatitis B and C prevent hepatocellular carcinoma?
    Lok AS
    J Gastroenterol Hepatol; 2011 Feb; 26(2):221-7. PubMed ID: 21070361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathologic characteristics andoutcomes of hepatocellular carcinoma associated with chronic hepatitis B versus hepatitis C infection.
    Aljumah AA; Kuriry H; Faisal N; Alghamdi H
    Ann Saudi Med; 2018; 38(5):358-365. PubMed ID: 30284991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural History of Chronic Hepatitis B Virus Infection in Ahvaz City, Iran.
    Makvandi M; Soleimani Jelodar R; Samarbafzadeh A; Neisi N; Sharifi Z; Gholampour A; Masjedizadeh A; Shayesteh A
    Asian Pac J Cancer Prev; 2018 Aug; 19(8):2125-2129. PubMed ID: 30139211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of occult hepatitis B virus infection on the outcome of chronic hepatitis C.
    Squadrito G; Cacciola I; Alibrandi A; Pollicino T; Raimondo G
    J Hepatol; 2013 Oct; 59(4):696-700. PubMed ID: 23751755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural history of compensated viral cirrhosis: a prospective study on the incidence and hierarchy of major complications.
    Benvegnù L; Gios M; Boccato S; Alberti A
    Gut; 2004 May; 53(5):744-9. PubMed ID: 15082595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis B: liver fibrosis and hepatocellular carcinoma.
    Lok AS
    Gastroenterol Clin Biol; 2009; 33(10-11):911-5. PubMed ID: 19577871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in surgical outcomes between hepatitis B- and hepatitis C-related hepatocellular carcinoma: a retrospective analysis of a single North American center.
    Franssen B; Alshebeeb K; Tabrizian P; Marti J; Pierobon ES; Lubezky N; Roayaie S; Florman S; Schwartz ME
    Ann Surg; 2014 Oct; 260(4):650-6; discussion 656-8. PubMed ID: 25203882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does antiviral therapy prevent hepatocellular carcinoma?
    Kwon H; Lok AS
    Antivir Ther; 2011; 16(6):787-95. PubMed ID: 21900710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Natural history of hepatitis B infection].
    Pol S
    Presse Med; 2006 Feb; 35(2 Pt 2):308-16. PubMed ID: 16493335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pathogenesis of hepatocellular carcinoma is multifactorial event. Novel immunological treatment in prospect.
    Marotta F; Vangieri B; Cecere A; Gattoni A
    Clin Ter; 2004 May; 155(5):187-99. PubMed ID: 15344567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of patients co-infected with HBV and HCV.
    Coffin CS; Terrault NA
    Expert Rev Anti Infect Ther; 2009 Jun; 7(5):549-58. PubMed ID: 19485795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural history and treatment of hepatitis B virus and hepatitis C virus coinfection.
    Crockett SD; Keeffe EB
    Ann Clin Microbiol Antimicrob; 2005 Sep; 4():13. PubMed ID: 16159399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current status of hepatitis C virus infection in Korea.
    Suh DJ; Jeong SH
    Intervirology; 2006; 49(1-2):70-5. PubMed ID: 16166792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Independent and additive interaction between tumor necrosis factor β +252 polymorphisms and chronic hepatitis B and C virus infection on risk and prognosis of hepatocellular carcinoma: a case-control study.
    Jeng JE; Wu HF; Tsai MF; Tsai HR; Chuang LY; Lin ZY; Hsieh MY; Chen SC; Chuang WL; Wang LY; Yu ML; Dai CY; Tsai JF
    Asian Pac J Cancer Prev; 2014; 15(23):10209-15. PubMed ID: 25556449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What can we learn from hepatitis B virus clinical cohorts?
    Lin CL; Tseng TC; Kao JH
    Liver Int; 2015 Jan; 35 Suppl 1():91-9. PubMed ID: 25529093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indications for liver transplantation in patients with chronic hepatitis B and C virus infection and hepatocellular carcinoma.
    Fan ST; Cheung ST; Lo CM
    J Gastroenterol Hepatol; 2000 May; 15 Suppl():E181-6. PubMed ID: 10921405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The natural history of chronic hepatitis B virus infection.
    Villeneuve JP
    J Clin Virol; 2005 Dec; 34 Suppl 1():S139-42. PubMed ID: 16461215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.